{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:21:36Z","timestamp":1793064096780,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/j.ijcard.2015.03.159","type":"journal-article","created":{"date-parts":[[2015,3,23]],"date-time":"2015-03-23T08:57:09Z","timestamp":1427101029000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"special_numbering":"C","title":["Is anemia a new cardiovascular risk factor?"],"prefix":"10.1016","volume":"186","author":[{"given":"Georgia","family":"Kaiafa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Kanellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christos","family":"Savopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5263-1803","authenticated-orcid":false,"given":"Nikolaos","family":"Kakaletsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Giannakoulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2323-8594","authenticated-orcid":false,"given":"Apostolos I.","family":"Hatzitolios","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ijcard.2015.03.159_bb0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00000542-199001000-00025","article-title":"Perioperative cardiac morbidity","volume":"72","author":"Mangano","year":"1990","journal-title":"Anesthesiology"},{"issue":"3","key":"10.1016\/j.ijcard.2015.03.159_bb0010","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.hfc.2010.02.003","article-title":"The economic burden of anemia in heart failure","volume":"6","author":"Spence","year":"2010","journal-title":"Heart Fail. Clin."},{"key":"10.1016\/j.ijcard.2015.03.159_bb0015","first-page":"5","article-title":"Nutritional anemias: report of a WHO scientific group","volume":"405","author":"World Health Organization","year":"1968"},{"issue":"14","key":"10.1016\/j.ijcard.2015.03.159_bb0020","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1093\/eurheartj\/ehr158","article-title":"ESC\/EAS guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)","volume":"32","author":"Reiner","year":"2011","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2015.03.159_bb0025","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amjcard.2008.10.023","article-title":"Reseau de Cardiologie de Franche Comte Anaemia for risk assessment of patients with acute coronary syndromes","volume":"103","author":"Meneveau","year":"2009","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2015.03.159_bb0030","first-page":"153","article-title":"Anemia and myocardial ischemia: relationships and interferences","volume":"97","author":"Bellotto","year":"2006","journal-title":"Recenti Prog. Med."},{"issue":"24","key":"10.1016\/j.ijcard.2015.03.159_bb0035","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.2169\/internalmedicine.50.5926","article-title":"Determinants of serum high molecular weight (HMW) adiponectin levels in patients with coronary artery disease: associations with cardio-renal-anemia syndrome","volume":"50","author":"Hara","year":"2011","journal-title":"Intern. Med."},{"issue":"6","key":"10.1016\/j.ijcard.2015.03.159_bb0040","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.amjmed.2011.10.025","article-title":"Endotheliac progenitor cells are suppressed in anemic patients with acute coronary syndrome","volume":"125","author":"Solomon","year":"2012","journal-title":"Am. J. Med."},{"issue":"10","key":"10.1016\/j.ijcard.2015.03.159_bb0045","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.amjcard.2010.07.009","article-title":"Relation between hemoglobin level and recurrent myocardial ischemia in acute coronary syndromes detected by continuous electrocardiographic monitoring","volume":"106","author":"Rousseau","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2015.03.159_bb0050","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3346\/jkms.2012.27.4.370","article-title":"Relation between anemia and vulnerable coronary plaque components in patients with acute coronary syndrome: virtual histology-intravascular ultrasound analysis","volume":"27","author":"Hong","year":"2012","journal-title":"J. Korean Med. Sci."},{"issue":"2","key":"10.1016\/j.ijcard.2015.03.159_bb0055","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/clc.22215","article-title":"Lower admission hemoglobin levels are associated with longer symptom duration in acute ST-elevation myocardial infarction","volume":"37","author":"Shacham","year":"2014","journal-title":"Clin. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcard.2015.03.159_bb0060","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.CIR.0000052617.91920.FD","article-title":"C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis","volume":"107","author":"Devaraj","year":"2003","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ijcard.2015.03.159_bb0065","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.amjcard.2011.05.026","article-title":"Recovery from hospital-acquired anemia after acute myocardial infarction and effect on outcomes","volume":"108","author":"Salisbury","year":"2011","journal-title":"Am. J. Cardiol."},{"issue":"7","key":"10.1016\/j.ijcard.2015.03.159_bb0070","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.amjcard.2013.12.017","article-title":"Variation in the incidence of hospital-acquired anemia during hospitalization with acute myocardial infarction (data from 57 US hospitals)","volume":"113","author":"Salisbury","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2015.03.159_bb0075","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCOUTCOMES.110.957050","article-title":"Incidence, correlates, and outcomes of acute, hospital-acquired anemia in patients with acute myocardial infarction","volume":"3","author":"Salisbury","year":"2010","journal-title":"Circ. Cardiovasc. Qual. Outcomes"},{"issue":"4","key":"10.1016\/j.ijcard.2015.03.159_bb0080","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ahj.2004.08.026","article-title":"An acute inflammatory reaction induced by myocardial damage is superimposed on a chronic inflammation in unstable coronary artery disease","volume":"149","author":"James","year":"2005","journal-title":"Am. Heart J."},{"issue":"21","key":"10.1016\/j.ijcard.2015.03.159_bb0085","doi-asserted-by":"crossref","first-page":"5277","DOI":"10.1182\/blood-2008-12-195651","article-title":"Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications","volume":"113","author":"Theurl","year":"2009","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ijcard.2015.03.159_bb0090","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/01.CIR.0000134964.01697.C7","article-title":"Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention","volume":"110","author":"McKechnie","year":"2004","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcard.2015.03.159_bb0095","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/MCA.0000000000000038","article-title":"Prognostic impact of anaemia on patients with ST-elevation myocardial infarction treated by primary PCI","volume":"25","author":"Rathod","year":"2014","journal-title":"Coron. Artery Dis."},{"issue":"3","key":"10.1016\/j.ijcard.2015.03.159_bb0100","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.jacc.2004.03.080","article-title":"Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial","volume":"44","author":"Nikolsky","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2015.03.159_bb0105","doi-asserted-by":"crossref","first-page":"e104495","DOI":"10.1371\/journal.pone.0104495","article-title":"Serum iron concentration, but not hemoglobin, correlates with TIMI risk score and 6-month left ventricular performance after primary angioplasty for acute myocardial infarction","volume":"9","author":"Huang","year":"2014","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ijcard.2015.03.159_bb0110","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.amjcard.2014.09.023","article-title":"Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the acute catheterization and urgent intervention triage strategy trial)","volume":"114","author":"Kunadian","year":"2014","journal-title":"Am. J. Cardiol."},{"issue":"16","key":"10.1016\/j.ijcard.2015.03.159_bb0115","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1161\/01.CIR.0000162477.70955.5F","article-title":"Association of hemoglobin levels with clinical outcomes in acute coronary syndromes","volume":"111","author":"Sabatine","year":"2005","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2015.03.159_bb0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ehj.2003.11.017","article-title":"Erythropoietin in cardiovascular disease","volume":"25","author":"Van der Meer","year":"2004","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2015.03.159_bb0125","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1046\/j.1523-1755.2003.00200.x","article-title":"Renal insufficiency and anemia are independent risk factors for death among patients with acute myocardial infarction","volume":"64","author":"Langston","year":"2003","journal-title":"Kidney Int."},{"issue":"16","key":"10.1016\/j.ijcard.2015.03.159_bb0130","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1161\/CIR.0b013e31829e8807","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcard.2015.03.159_bb0135","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/eurjhf\/hfs105","article-title":"ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012","volume":"14","author":"McMurray","year":"2012","journal-title":"Eur. J. Heart Fail."},{"issue":"2","key":"10.1016\/j.ijcard.2015.03.159_bb0140","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.cardfail.2004.05.004","article-title":"Anemia in patients with heart failure: prevalence and prognostic role in a controlled trail and in clinical practice","volume":"11","author":"Maggioni","year":"2005","journal-title":"J. Card. Fail."},{"issue":"3","key":"10.1016\/j.ijcard.2015.03.159_bb0145","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.jacc.2004.10.038","article-title":"Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction","volume":"45","author":"Ishani","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2015.03.159_bb0150","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0828-282X(08)70547-6","article-title":"Temporal variations in hematocrit values in patients with left ventricular dysfunction: relationship with cause-specific mortality and morbidity and optimal monitoring\u2014further insights from SOLVD","volume":"24","author":"de Denus","year":"2008","journal-title":"Can. J. Cardiol."},{"issue":"8","key":"10.1016\/j.ijcard.2015.03.159_bb0155","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1161\/CIRCULATIONAHA.104.512988","article-title":"Anemia and change in hemoglobin over time related to mortality and morbidity in patients with chronic heart failure: results from Val-HeFT","volume":"112","author":"Anand","year":"2005","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.ijcard.2015.03.159_bb0160","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1093\/eurheartj\/ehl012","article-title":"The impact of new onset anemia on morbidity and mortality in chronic heart failure: results from COMET","volume":"27","author":"Komajda","year":"2006","journal-title":"Eur. Heart J."},{"issue":"12","key":"10.1016\/j.ijcard.2015.03.159_bb0165","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.ehj.2004.04.023","article-title":"Haemoglobin predicts survival in patients with chronic heart failure: a substudy of the ELITE II trial","volume":"25","author":"Sharma","year":"2004","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcard.2015.03.159_bb0170","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1161\/01.CIR.0000134279.79571.73","article-title":"Anemia and its relationship to clinical outcome in heart failure","volume":"110","author":"Anand","year":"2004","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ijcard.2015.03.159_bb0175","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/CIRCULATIONAHA.105.582577","article-title":"Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) program","volume":"113","author":"O'Meara","year":"2006","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ijcard.2015.03.159_bb0180","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S0735-1097(00)00613-6","article-title":"The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalization","volume":"35","author":"Silverberg","year":"2000","journal-title":"J. Am. Coll. Cardiol."},{"issue":"14","key":"10.1016\/j.ijcard.2015.03.159_bb0185","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/eurheartj\/ehs104","volume":"33","author":"McMurray","year":"2012","journal-title":"Eur. Heart J."},{"issue":"15","key":"10.1016\/j.ijcard.2015.03.159_bb0190","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1093\/eurheartj\/ehq158","article-title":"Iron deficiency: an ominous sign in patients with systolic chronic heart failure","volume":"31","author":"Jankowska","year":"2010","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcard.2015.03.159_bb0195","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/BF01058569","article-title":"Body iron status in critically patients: significance of serum ferritin","volume":"15","author":"Bobbio-Pallavicini","year":"1989","journal-title":"Intensive Care Med."},{"issue":"Suppl. B","key":"10.1016\/j.ijcard.2015.03.159_bb0200","first-page":"B2","article-title":"Oxidative stress during myocardial ischaemia and heart failure","volume":"19","author":"Ferrari","year":"1998","journal-title":"Eur. Heart J."},{"issue":"21","key":"10.1016\/j.ijcard.2015.03.159_bb0205","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1093\/eurheartj\/ehi388","article-title":"Blunted erythropoietin production and defective iron supply for erythropoiesis as major causes of anemia in patients with chronic heart failure","volume":"26","author":"Opasich","year":"2005","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.ijcard.2015.03.159_bb0210","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1152\/ajpregu.2002.282.1.R166","article-title":"Decrease hematopoiesis in bone narrow of mice with congestive heart failure","volume":"282","author":"Iversen","year":"2002","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"2","key":"10.1016\/j.ijcard.2015.03.159_bb0215","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1161\/01.CIR.0000052623.16194.80","article-title":"Hemodilution is common in patients with advanced heart failure","volume":"107","author":"Androne","year":"2003","journal-title":"Circulation"},{"issue":"33","key":"10.1016\/j.ijcard.2015.03.159_bb0220","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1136\/hrt.66.3.199","article-title":"Induction of a reduction in hemoglobin concentration by enalapril in stable, moderate heart failure: a double-blind study","volume":"66","author":"Herrlin","year":"1991","journal-title":"Br. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2015.03.159_bb0225","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S1388-9842(00)00110-0","article-title":"Serum erythropoietin in heart failure patients treated with ACE-inhibitors or AT (1) antagonists","volume":"2","author":"Chatterjee","year":"2000","journal-title":"Eur. J. Heart Fail."},{"issue":"20","key":"10.1016\/j.ijcard.2015.03.159_bb0230","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1161\/CIRCULATIONAHA.105.583666","article-title":"Anemia in chronic heart failure: prevalence, etiology, clinical correlates, and treatment options","volume":"113","author":"Tang","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ijcard.2015.03.159_bb0235","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11897-004-0006-7","article-title":"Anemia and heart failure","volume":"1","author":"O'Meara","year":"2004","journal-title":"Curr. Heart Fail. Rep."},{"issue":"Suppl. 7","key":"10.1016\/j.ijcard.2015.03.159_bb0240","doi-asserted-by":"crossref","first-page":"vii7","DOI":"10.1093\/ndt\/gfh1100","article-title":"Anaemia and heart failure: aetiology and treatment","volume":"20","author":"Klutstein","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"issue":"11","key":"10.1016\/j.ijcard.2015.03.159_bb0245","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/S0735-1097(03)00425-X","article-title":"Anemia predicts mortality in severe heart failure: the prospective randomized amlodipine survival evaluation (PRAISE)","volume":"41","author":"Mozaffarian","year":"2003","journal-title":"J. Am. Coll. Cardiol."},{"issue":"Suppl. A","key":"10.1016\/j.ijcard.2015.03.159_bb0250","doi-asserted-by":"crossref","first-page":"216A","DOI":"10.1016\/S0735-1097(04)90919-9","article-title":"Hemoglobin level is associated with mortality and hospitalization in patients with severe chronic heart failure: results from the COPERNICUS study (abstr)","volume":"43","author":"Anker","year":"2004","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6852","key":"10.1016\/j.ijcard.2015.03.159_bb0255","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/35093117","article-title":"S-nitrosothiols signal the ventilatory response to hypoxia","volume":"413","author":"Lipton","year":"2001","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.ijcard.2015.03.159_bb0260","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1136\/hrt.2008.161091","article-title":"Erythropoietin treatment in patients with chronic heart failure: a meta-analysis","volume":"95","author":"Van der Meer","year":"2009","journal-title":"Heart"},{"issue":"12","key":"10.1016\/j.ijcard.2015.03.159_bb0265","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1016\/j.jacc.2006.08.034","article-title":"Etiology of anemia in patients with advanced heart failure","volume":"48","author":"Nanas","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"issue":"11","key":"10.1016\/j.ijcard.2015.03.159_bb0270","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/eurjhf\/hft099","article-title":"Intravenous ferric carboxymaltose in iron-deficient chronic heart failure patients with and without anaemia: a subanalysis of the FAIR-HF trial","volume":"15","author":"Filippatos","year":"2013","journal-title":"Eur. J. Heart Fail."},{"issue":"11","key":"10.1016\/j.ijcard.2015.03.159_bb0275","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/eurheartj\/ehu385","article-title":"Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency","volume":"36","author":"Ponikowski","year":"2015","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2015.03.159_bb0280","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1016\/j.ijcard.2013.04.181","article-title":"IRON-HF study: a randomized trial to assess the effects of iron in heart failure patients with anemia","volume":"168","author":"Beck-da-Silva","year":"2013","journal-title":"Int. J. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2015.03.159_bb0285","doi-asserted-by":"crossref","first-page":"645.e9","DOI":"10.1016\/j.ahj.2007.07.022","article-title":"Effects of beta-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal anemia syndrome","volume":"154","author":"Palazzuoli","year":"2007","journal-title":"Am. Heart J."},{"issue":"4","key":"10.1016\/j.ijcard.2015.03.159_bb0290","first-page":"461","article-title":"Role of iron in optimizing responses of anemic cancer patients to erythropoietin","volume":"13","author":"Glaspy","year":"1999","journal-title":"Oncology"},{"key":"10.1016\/j.ijcard.2015.03.159_bb0295","doi-asserted-by":"crossref","first-page":"S61","DOI":"10.1046\/j.1523-1755.1999.055Suppl.69061.x","article-title":"Strategies for iron supplementation: oral versus intravenous","volume":"69","author":"MacDougall","year":"1999","journal-title":"Kidney Int. Suppl."},{"issue":"9","key":"10.1016\/j.ijcard.2015.03.159_bb0300","doi-asserted-by":"crossref","first-page":"525","DOI":"10.5694\/j.1326-5377.2010.tb04038.x","article-title":"Diagnosis and management of iron deficiency anaemia: a clinical update","volume":"193","author":"Pasricha","year":"2010","journal-title":"Med. J. Aust."},{"issue":"9586","key":"10.1016\/j.ijcard.2015.03.159_bb0305","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(07)61225-2","article-title":"Long-term risks of increased use of intravenous iron","volume":"370","author":"Sullivan","year":"2007","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.ijcard.2015.03.159_bb0310","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1681\/ASN.2007101084","article-title":"Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients","volume":"19","author":"Kuo","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijcard.2015.03.159_bb0315","doi-asserted-by":"crossref","first-page":"169107","DOI":"10.1155\/2013\/169107","article-title":"Direct comparison of the safety and efficacy of ferric carboxymaltose versus iron dextran in patients with iron deficiency anemia","volume":"2013","author":"Hussain","year":"2013","journal-title":"Anemia"},{"issue":"7","key":"10.1016\/j.ijcard.2015.03.159_bb0320","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1093\/eurjhf\/hft068","article-title":"The effect of intravenous ferric carboxymaltose on red cell distribution width: a subanalysis of the FAIR-HF study","volume":"15","author":"Van Craenenbroeck","year":"2013","journal-title":"Eur. J. Heart Fail."},{"issue":"1","key":"10.1016\/j.ijcard.2015.03.159_bb0325","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2010.08.046","article-title":"Characteristics and outcomes among heart failure patients with anemia and renal insufficiency with and without blood transfusions (public discharge data from California 2000\u20132006)","volume":"107","author":"Kao","year":"2011","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.ijcard.2015.03.159_bb0330","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.atherosclerosis.2007.09.039","article-title":"Effects of darbepoetin-alpha on plasma pro-inflammatory cytokines, anti-inflammatory cytokine interleukin-10 and soluble Fas\/Fas ligand system in anemic patients with chronic heart failure","volume":"199","author":"Kourea","year":"2008","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.ijcard.2015.03.159_bb0335","doi-asserted-by":"crossref","first-page":"751.e1","DOI":"10.1016\/j.ahj.2008.01.016","article-title":"Effects of darbepoetin \u03b1 on right and left ventricular systolic and diastolic function in anemic patients with chronic heart failure secondary to ischemic or idiopathic dilated cardiomyopathy","volume":"155","author":"Parissis","year":"2008","journal-title":"Am. Heart J."},{"issue":"9","key":"10.1016\/j.ijcard.2015.03.159_bb0340","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1096\/fj.03-1289fje","article-title":"Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury","volume":"18","author":"Wright","year":"2004","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.ijcard.2015.03.159_bb0345","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1161\/CIRCULATIONAHA.107.698514","article-title":"Randomized double-blind trial of darbepoetin alfa in patients with symptomatic heart failure and anemia (STAMINA-HeFT study)","volume":"117","author":"Ghali","year":"2008","journal-title":"Circulation"},{"issue":"Suppl. 2","key":"10.1016\/j.ijcard.2015.03.159_bb0350","first-page":"ii13","article-title":"CREATE: new strategies for early anaemia management in renal insufficiency","volume":"18","author":"Macdougall","year":"2003","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.ijcard.2015.03.159_bb0355","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.ajkd.2012.03.009","article-title":"Effect of Haemoglobin target on progression of kidney disease: a secondary analysis of the CHOIR (Correction of Hemoglobin and Outcomes in Renal Insufficiency) trial","volume":"60","author":"Inrig","year":"2012","journal-title":"Am. J. Kidney Dis."},{"issue":"21","key":"10.1016\/j.ijcard.2015.03.159_bb0360","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1056\/NEJMoa0907845","article-title":"A trial of darbepoetin alfa in type II diabetes and chronic kidney disease","volume":"361","author":"Pfeffer","year":"2009","journal-title":"N. Engl. J. Med."},{"issue":"13","key":"10.1016\/j.ijcard.2015.03.159_bb0365","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa1214865","article-title":"Treatment of anemia with darbepoetin alfa in systolic heart failure","volume":"368","author":"Swedberg","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.ijcard.2015.03.159_bb0370","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(03)01163-X","article-title":"Breast cancer trial with erythropoietin terminated unexpectedly","volume":"4","author":"Leyland-Jones","year":"2003","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ijcard.2015.03.159_bb0375","author":"National Kidney Foundation Kidney Disease Outcomes Quality Initiative"},{"issue":"1","key":"10.1016\/j.ijcard.2015.03.159_bb0380","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0735-1097(02)01938-1","article-title":"Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study","volume":"40","author":"Sarnak","year":"2002","journal-title":"J. Am. Coll. Cardiol."},{"issue":"4","key":"10.1016\/j.ijcard.2015.03.159_bb0385","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1067\/mhj.2001.118467","article-title":"Hematocrit and risk of coronary heart disease","volume":"142","author":"Brawn","year":"2001","journal-title":"Am. Heart J."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315003988?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527315003988?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T03:00:57Z","timestamp":1598842857000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527315003988"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":77,"alternative-id":["S0167527315003988"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.159","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is anemia a new cardiovascular risk factor?","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2015.03.159","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}